James Basta
General Counsel at INTELLIA THERAPEUTICS, INC.
Net worth: 2 M $ as of 30/04/2024
Profile
James Basta is currently the Secretary, Executive VP & General Counsel at Intellia Therapeutics, Inc. He previously worked as the Chief Corporation Counsel & Senior Vice President at Biogen, Inc., Secretary, Chief Legal & Compliance Officer at Kura Oncology, Inc., and Partner at Baker & McKenzie LLP (Illinois).
He received his undergraduate degree from Northwestern University and his graduate degree from Northwestern University School of Law.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 04/03/2024 | 81,571 ( 0.08% ) | 2 M $ | 30/04/2024 |
James Basta active positions
| Companies | Position | Start |
|---|---|---|
| INTELLIA THERAPEUTICS, INC. | General Counsel | 24/06/2021 |
Former positions of James Basta
| Companies | Position | End |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | - |
Baker & McKenzie LLP (Illinois)
 Baker & McKenzie LLP (Illinois) Miscellaneous Commercial ServicesCommercial Services Baker & McKenzie LLP provides legal services. The company was founded in 1949 and is headquartered in Chicago, IL. | Corporate Officer/Principal | - |
| KURA ONCOLOGY, INC. | Compliance Officer | - |
Training of James Basta
| Northwestern University | Undergraduate Degree |
| Northwestern University School of Law | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| KURA ONCOLOGY, INC. | Health Technology |
| BIOGEN INC. | Health Technology |
| INTELLIA THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Baker & McKenzie LLP (Illinois)
Baker & McKenzie LLP (Illinois) Miscellaneous Commercial ServicesCommercial Services Baker & McKenzie LLP provides legal services. The company was founded in 1949 and is headquartered in Chicago, IL. | Commercial Services |
- Stock Market
- Insiders
- James Basta
